Norepinephrine in the Prefrontal Cortex Is Critical for Amphetamine-Induced Reward and Mesoaccumbens Dopamine Release

Increasing evidence points to a major involvement of cortical areas in addictive mechanisms. Noradrenergic transmission in the medial prefrontal cortex (mpFC) has been shown to affect the motor effects of amphetamine, although there is no evidence of its involvement in the rewarding effects of this psychostimulant. The present experiments were aimed at investigating the possibility of a selective involvement of prefrontal cortical norepinephrine (NE) in the rewarding–reinforcing effects of amphetamine. To do so, we evaluated the effects of mpFC NE selective depletion in mice of C57BL/6J inbred strain, a background commonly used in molecular approaches that is known to be highly susceptible to the rewarding effects of the psychostimulant. In a first set of experiments, we demonstrated the absence of amphetamine-induced conditioned place preference in mice bearing prefrontal NE depletion. In a second series of experiments, we demonstrated that the same lesion dramatically reduced amphetamine-induced mesoaccumbens dopamine release as measured by intracerebral microdialysis. These results indicate that noradrenergic prefrontal transmission, by allowing increased dopamine release in the nucleus accumbens induced by amphetamine, is a critical factor for the rewarding–reinforcing effects of this drug.

[1]  R. Summers,et al.  Role of adrenoceptor subtypes in memory consolidation , 2002, Progress in Neurobiology.

[2]  Trevor W. Robbins,et al.  Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions ofd-amphetamine , 1993, Behavioural Brain Research.

[3]  I. Whishaw,et al.  Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats , 1992, Brain Research.

[4]  C. Fiorillo,et al.  Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons , 2001, Nature Neuroscience.

[5]  H. Simon,et al.  Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus , 1996, Psychopharmacology.

[6]  M. Millan,et al.  Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. , 1997, European journal of pharmacology.

[7]  M. Packard,et al.  The amygdala mediates memory consolidation for an amphetamine conditioned place preference , 2002, Behavioural Brain Research.

[8]  N. White,et al.  Anatomical disassociation of amphetamine's rewarding and aversive effects: An intracranial microinjection study , 2004, Psychopharmacology.

[9]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[10]  D. Weinberger,et al.  Local and Downstream Effects of Excitotoxic Lesions in the Rat Medial Prefrontal Cortex on In Vivo 1H-MRS Signals , 2000, Neuropsychopharmacology.

[11]  K. Berridge,et al.  Incentive-sensitization and addiction. , 2001, Addiction.

[12]  M. Kano,et al.  Modest Neuropsychological Deficits Caused by Reduced Noradrenaline Metabolism in Mice Heterozygous for a Mutated Tyrosine Hydroxylase Gene , 2000, The Journal of Neuroscience.

[13]  G. Di Chiara The role of dopamine in drug abuse viewed from the perspective of its role in motivation. , 1995, Drug and alcohol dependence.

[14]  U. Ungerstedt,et al.  Neurochemical Correlates of Cocaine and Ethanol Self‐Administration a , 1992, Annals of the New York Academy of Sciences.

[15]  M. Olmstead,et al.  Differential effects of ventral striatal lesions on the conditioned place preference induced by morphine or amphetamine , 1996, Neuroscience.

[16]  J. Glowinski,et al.  Blockade of Prefronto‐cortical α1‐Adrenergic Receptors Prevents Locomotor Hyperactivity Induced by Subcortical D‐Amphetamine Injection , 1994, The European journal of neuroscience.

[17]  R. Wise,et al.  Brain dopamine and reward. , 1989, Annual review of psychology.

[18]  W. Schmidt,et al.  Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm , 1998, Behavioural Brain Research.

[19]  B. Yamamoto,et al.  The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. , 1998, The Journal of pharmacology and experimental therapeutics.

[20]  C. Carter,et al.  Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat , 1980, Brain Research.

[21]  D. Segal,et al.  Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine , 1997, Journal of neurochemistry.

[22]  E. Abercrombie,et al.  Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  J. Glowinski,et al.  Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of d-Amphetamine , 1998, The Journal of Neuroscience.

[24]  R. Schwarting,et al.  Intraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activity , 1998, Brain Research.

[25]  B. Westerink,et al.  The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. , 1998, The Journal of pharmacology and experimental therapeutics.

[26]  J. Glowinski,et al.  d-Amphetamine Fails to Increase Extracellular Dopamine Levels in Mice Lacking α1b-Adrenergic Receptors: Relationship between Functional and Nonfunctional Dopamine Release , 2002, The Journal of Neuroscience.

[27]  A. C. Roberts,et al.  Perseveration and Strategy in a Novel Spatial Self-Ordered Sequencing Task for Nonhuman Primates: Effects of Excitotoxic Lesions and Dopamine Depletions of the Prefrontal Cortex , 1998, Journal of Cognitive Neuroscience.

[28]  J. Glowinski,et al.  Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the d-amphetamine-induced release of functional dopamine , 2001, Neuroscience.

[29]  Fei Xu,et al.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants , 2000, Nature Neuroscience.

[30]  T. Tzschentke,et al.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues , 1998, Progress in Neurobiology.

[31]  T. Robbins,et al.  Drug addiction: bad habits add up , 1999, Nature.

[32]  G. Di Chiara,et al.  Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Volkow,et al.  The neuroscience of addiction , 2005, Nature Neuroscience.

[34]  T. Robbins,et al.  Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens , 1999, The European journal of neuroscience.

[35]  J. Glowinski,et al.  α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates , 2002, The Journal of Neuroscience.

[36]  M. Le Moal,et al.  Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. , 2000, Science.

[37]  Giuseppe Esposito,et al.  Dextroamphetamine Enhances “Neural Network-Specific” Physiological Signals: A Positron-Emission Tomography rCBF Study , 1996, The Journal of Neuroscience.

[38]  Werner J. Schmidt,et al.  6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze , 1990, Behavioural Brain Research.

[39]  I. Tulloch,et al.  Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. , 1988, Psychopharmacology.

[40]  W. Pan,et al.  Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. , 1996, The Journal of pharmacology and experimental therapeutics.

[41]  S. Cabib,et al.  PSYCHOPHARMACOLOGY OF DOPAMINE: THE CONTRIBUTION OF COMPARATIVE STUDIES IN INBRED STRAINS OF MICE , 1997, Progress in Neurobiology.

[42]  D. Segal,et al.  Behavioral effects of xylamine-induced depletions of brain norepinephrine: Interaction with amphetamine , 1986, Behavioural Brain Research.

[43]  G. Chiara The role of dopamine in drug abuse viewed from the perspective of its role in motivation , 1995 .

[44]  T. Lewander,et al.  Central noradrenaline depletion antagonizes aspects ofd-amphetamine-induced hyperactivity in the rat , 2004, Psychopharmacology.

[45]  S. Stanford,et al.  A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo , 1998, Psychopharmacology.

[46]  S. Cabib,et al.  Psychopharmacology of memory modulation: Evidence for multiple interaction among neurotransmitters and hormones , 1996, Behavioural Brain Research.

[47]  P. Vezina Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat , 1993, Brain Research.

[48]  T. Archer,et al.  Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior , 1986, Neuroscience Letters.

[49]  S. Cabib,et al.  Opposite genotype-dependent mesocorticolimbic dopamine response to stress , 2001, Neuroscience.

[50]  J. Glowinski,et al.  Critical role of α1‐adrenergic receptors in acute and sensitized locomotor effects of D‐amphetamine, cocaine, and GBR 12783: Influence of preexposure conditions and pharmacological characteristics , 2002, Synapse.

[51]  J. Tassin Norepinephrine-dopamine interactions in the prefrontal cortex and the ventral tegmental area: relevance to mental diseases. , 1998, Advances in pharmacology.

[52]  I. Tulloch,et al.  α1- and α2-Adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced byd-amphetamine and apomorphine in the rat , 2005, Psychopharmacology.

[53]  J S Fowler,et al.  Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. , 2000, Cerebral cortex.

[54]  R. Tessel,et al.  Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. , 1985, European journal of pharmacology.

[55]  A. J Spink,et al.  The EthoVision video tracking system—A tool for behavioral phenotyping of transgenic mice , 2001, Physiology & Behavior.

[56]  B. Bunney,et al.  Dual Effects of d-Amphetamine on Dopamine Neurons Mediated by Dopamine and Nondopamine Receptors , 2000, The Journal of Neuroscience.

[57]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[58]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.